ENVB Insider Trading

Insider Ownership Percentage: 1.20%
Insider Buying (Last 12 Months): $2,140.00
Insider Selling (Last 12 Months): $0.00

Enveric Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Enveric Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Enveric Biosciences Share Price & Price History

Current Price: $0.98
Price Change: Price Increase of +0.05 (5.38%)
As of 05/3/2024 01:00 AM ET

This chart shows the closing price history over time for ENVB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Enveric Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/15/2023Frank PasqualoneDirectorBuy1,000$2.14$2,140.001,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Enveric Biosciences (NASDAQ:ENVB)

13.82% of Enveric Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ENVB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Enveric Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2024Armistice Capital LLC273,000$0.36M0.0%N/A9.964%Search for SEC Filing on Google Icon
11/6/2023AdvisorShares Investments LLC146,833$0.34M0.1%+46.2%6.729%Search for SEC Filing on Google Icon
8/9/2023AdvisorShares Investments LLC100,429$0.34M0.1%-29.8%4.828%Search for SEC Filing on Google Icon
5/9/2023AdvisorShares Investments LLC143,016$0.24M0.1%+23.0%6.876%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC223,834$48K0.0%-47.2%21.237%Search for SEC Filing on Google Icon
8/8/2022AdvisorShares Investments LLC1,252,390$0.27M0.1%+35.8%118.823%Search for SEC Filing on Google Icon
5/10/2022Mirae Asset Global Investments Co. Ltd.286,267$94K0.0%-27.1%0.544%Search for SEC Filing on Google Icon
5/9/2022AdvisorShares Investments LLC922,371$0.30M0.1%+206.9%1.754%Search for SEC Filing on Google Icon
2/8/2022Mirae Asset Global Investments Co. Ltd.392,920$0.37M0.0%N/A1.252%Search for SEC Filing on Google Icon
1/31/2022AdvisorShares Investments LLC300,524$0.28M0.0%+740.5%0.958%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC13,273$27K0.0%N/A0.062%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC492,553$1.02M0.0%N/A2.298%Search for SEC Filing on Google Icon
11/12/2021Vident Investment Advisory LLC25,152$52K0.0%N/A0.117%Search for SEC Filing on Google Icon
11/12/2021Scotia Capital Inc.94,395$0.20M0.0%N/A0.440%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.500,078$1.04M0.0%-1.8%2.334%Search for SEC Filing on Google Icon
11/4/2021AdvisorShares Investments LLC35,754$74K0.0%N/A0.167%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC52,943$0.13M0.0%-70.8%0.247%Search for SEC Filing on Google Icon
8/16/2021State Street Corp88,886$0.21M0.0%N/A0.416%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp36,504$87K0.0%+228.5%0.171%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC98,894$0.24M0.0%+56.7%0.462%Search for SEC Filing on Google Icon
8/12/2021Penserra Capital Management LLC26,986$52K0.0%N/A0.126%Search for SEC Filing on Google Icon
8/4/2021Creative Planning17,577$42K0.0%N/A0.082%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC181,254$0.56M0.0%+1,623.9%0.828%Search for SEC Filing on Google Icon
5/17/2021Schonfeld Strategic Advisors LLC20,400$62K0.0%N/A0.093%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp21,021$65K0.0%N/A0.096%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp11,111$34K0.0%N/A0.051%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC63,094$0.19M0.0%N/A0.288%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG31,472$97K0.0%N/A0.144%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.563,520$1.73M0.0%N/A2.575%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC10,514$45K0.0%N/A0.069%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Enveric Biosciences logo
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Read More on Enveric Biosciences

Today's Range

Now: $0.98
Low: $0.92
High: $1.02

50 Day Range

MA: $1.06
Low: $0.83
High: $1.66

52 Week Range

Now: $0.98
Low: $0.65
High: $6.98

Volume

203,914 shs

Average Volume

118,333 shs

Market Capitalization

$7.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

Who are the company insiders with the largest holdings of Enveric Biosciences?

Enveric Biosciences' top insider investors include:
  1. Frank Pasqualone (Director)
Learn More about top insider investors at Enveric Biosciences.